The director general of the National Agency for Food and Drug Administration and Control, Professor Mojisola Adeyeye, has approved the production of chloroquine for clinical trial in the search for a cure for COVID-19.
Making the announcement on Friday at the NAFDAC headquarters in Lagos, She clearly emphasized that NAFDAC is not approving Chloroquine for the treatment of COVID-19 but only for clinical trials, to possibly find treatment for the virus.
She therefore called on experts and researchers , who are interested in doing a clinical trial on Chloroquine, to approach approved outlets.
Advertisement
For now, only one company has been contracted to make a batch of Chloroquine for the purpose of the clinical trial
Related posts:
Nigeria ignores W.H.O continues chloroquine clinical test trials
LASG approves clinical trial of Ivermectin for Covid-19
COVID-19: WHO resumes clinical trial of Hydroxychloroquine
COVID-19: WHO to commence worldwide clinical trial of three new drugs
COVID-19: China approves two vaccines for clinical trials
COVID-19: NAFDAC approves Moderna, Astrazeneca, conditionally approves Sputnik V vaccines
We have revolutionized NAFDAC– Director General, NAFDAC
U.K Scientists begin Clinical trials of COVID-19 Vaccine
